We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

CRISPR and Genome Editing – News and Features

News

Cloned Human Embryos Successfully Reprogrammed Using Human Eggs

Study by Advanced Cell Technology and collaborators questions ability of human-animal hybrids to generate stem cells.
News

Neurologix Commences its Phase II Clinical Trial of Gene Transfer Approach for Treatment of Parkinson's Disease

The first trial participants have undergone surgery at multiple institutions and additional subjects are currently being enrolled.
News

Gene Marker May Improve Odds of Stem Cell Therapies for Disease

A single tumor-suppressor gene may provide a unique marker for senescence in MSCs in vitro, while also playing a role in moving MSCs into senescence.
News

GeneWorks Forms Commercial Alliance with Horizon Discovery

GeneWorks to offer translational genomics capabilities to researchers in Australia and New Zealand.
News

Technique for Creating Authentic Rat Embryonic Stem Cells

The technique licensed exclusively by Stem Cell Sciences, is expected to allow the generation of rat ES cells to create genetically modified animals.
News

Embryonic Stem Cells from Rats Derived

The breakthrough finding will enable scientists to create more effective animal models for the study of a range of human diseases.
News

Biologists Learn Structure, Mechanism of Powerful 'Molecular Motor' in Virus

Researchers have discovered the atomic structure of a powerful "molecular motor" that packages DNA into the head segment of some viruses during their assembly.
News

nanoTherics Wins R&D Grant from Advantage West Midlands to Further Augment Gene Transfection Product Portfolio

The grant will enable the Company to progress development of additional novel gene transfection technologies to augment its product portfolio.
News

Mouse Studies Show Gene Therapy Method Holds Promise in Targeting Tumor Blood Vessels for Destruction

Researchers develop a method for delivering a therapeutic gene to the blood vessels of tumors in mice that damages the blood vessels and disrupts the blood flow to tumors.
News

Sloan Foundation Supports Hastings Center Work on Ethical Issues in Synthetic Biology

The Hastings Center has received a $500,000 grant to spend two years delving into the ethical issues surrounding synthetic biology.
Advertisement